Role of tumor margin and ADC change in defining the need for additional treatments after the first TACE in patients with unresectable HCC

Shaghaghi, M; Hasabeh, MA; Ameli, S; Ghadimi, M; Hazhirkarzar, B; Habibabadi, RR; Tang, H; Khoshpouri, P; Wu, QX; Pandey, A; Pandey, P; Baghdadi, A; Kamel, IR

EUROPEAN JOURNAL OF RADIOLOGY, 2020; 133 ():

Abstract

Purpose: To define the number of TACE sessions needed to improve patients' overall survival (OS) in different subgroups of unresectable HCC. Methods: ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索